CORC

浏览/检索结果: 共4条,第1-4条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Dual Inhibition of Bcr-Abl and Hsp90 by C086 Potently Inhibits the Proliferation of Imatinib-Resistant CML Cells 期刊论文
CLINICAL CANCER RESEARCH, 2015, 卷号: 21, 期号: 4, 页码: 833-843
作者:  Wu, Lixian;  Yu, Jing;  Chen, Ruijia;  Liu, Yang;  Lou, Liguang
收藏  |  浏览/下载:37/0  |  提交时间:2019/01/08
Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro 期刊论文
ACTA PHARMACOLOGICA SINICA, 2014, 卷号: 35, 期号: 3, 页码: 401-409
作者:  Wu, Li-xian;  Wu, Ying;  Chen, Rui-jia;  Liu, Yang;  Huang, Li-sen
收藏  |  浏览/下载:20/0  |  提交时间:2019/01/08
Flumatinib, a selective inhibitor of BCR-ABL/PDGFR/KIT, effectively overcomes drug resistance of certain KIT mutants 期刊论文
CANCER SCIENCE, 2014, 卷号: 105, 期号: 1, 页码: 117-125
作者:  Zhao, Jie;  Quan, Haitian;  Xu, Yongping;  Kong, Xiangqian;  Jin, Lu
收藏  |  浏览/下载:26/0  |  提交时间:2019/01/08
Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting Epidermal Growth Factor Receptor Threonine(790) -> Methionine(790) Mutant 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 卷号: 55, 期号: 6, 页码: 2711-2723
作者:  Chang, Shaohua;  Zhang, Lianwen;  Xu, Shilin;  Luo, Jinfeng;  Lu, Xiaoyun
收藏  |  浏览/下载:18/0  |  提交时间:2019/01/08


©版权所有 ©2017 CSpace - Powered by CSpace